SCHEMBL7835294

SCHEMBL7835294

CCCN1[CH]Cc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
ADRA2B P18089 3/20 0.42
ADRA2C P18825 3/20 0.42
ADRA2A P08913 2/20 0.42
LMNA P02545 5/20 0.38
DRD2 P14416 5/20 0.38
MAPT P10636 4/20 0.38
KDM4E B2RXH2 4/20 0.38
CYP2D6 P10635 3/20 0.38
DRD3 P35462 3/20 0.38
CHRM2 P08172 2/20 0.38
CHRM4 P08173 2/20 0.38
CHRM5 P08912 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
DRD4 P21917 2/20 0.38
HTR3E A5X5Y0 1/20 0.38
SLC22A2 O15244 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7835662 0.89 DRD2 (0.44) ALDH1A1MEN1KMT2AADRA2BADRA2C
SCHEMBL1100574 0.87 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AADRA2BADRA2C
SCHEMBL7835140 0.84 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AADRA2BADRA2C
SCHEMBL9008263 0.81 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AADRA2BADRA2C
SCHEMBL6197328 0.81 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AADRA2BADRA2C
SCHEMBL3096254 0.77 NPC1 (0.46) ALDH1A1MEN1KMT2ALMNADRD2
SCHEMBL3098200 0.73 LMNA (0.47) ALDH1A1LMNADRD2DRD4SLC6A4
SCHEMBL827824 0.73 ALDH1A1 (0.39) ALDH1A1MEN1KMT2AADRA2BADRA2C
SCHEMBL15422618 0.72 DRD2 (0.43) ALDH1A1MEN1KMT2AADRA2BADRA2C
SCHEMBL19436608 0.70 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ALMNADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed